Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411578 · ClinicalTrials.gov registry record · Phase 2
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
A Phase 2 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT02411578 is a Phase 2 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 26 participants.
The verdict
NCT02411578, a Phase 2 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a small dose of glucagon (mini-dose glucagon) is effective for the treatment of non-severe hypoglycemia in adults with type 1 diabetes (T1D).
Interventions
- DRUG G-Pen Mini™ (glucagon injection)
- OTHER Glucose Tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02411578
The ClinicalTrials.gov registry entry for NCT02411578 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which G-Pen Mini™ (glucagon injection) is the first listed.
NCT02411578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02411578 about?
NCT02411578 is a clinical study titled "Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia". The purpose of this study is to determine if a small dose of glucagon (mini-dose glucagon) is effective for the treatment of non-severe hypoglycemia in adults with type 1 diabetes (T1D).
What is the current status of trial NCT02411578?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2015-09. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02411578?
The interventions under investigation include: G-Pen Mini™ (glucagon injection) (DRUG), Glucose Tablets (OTHER).
Who is sponsoring clinical trial NCT02411578?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.